Molecularly targeted therapy for metastatic cancer: 1,25-dihydroxyvitamin D suppresses the expression of oncogenic RNA MALAT1 via up regulation of its target gene, 15/February/2014, 12.35 pm

Molecularly targeted therapy for metastatic cancer: 1,25-dihydroxyvitamin D suppresses the expression of oncogenic RNA MALAT1 via up regulation of its target gene, 15/February/2014, 12.35 pm

Molecularly targeted therapy for metastatic cancer: 1,25-dihydroxyvitamin D suppresses the expression of oncogenic RNA MALAT1 via up regulation of its target gene, 15/February/2014, 12.35 pm 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan,  Molecularly targeted therapy for metastatic cancer: 1,25-dihydroxyvitamin D suppresses the expression of oncogenic RNA MALAT1 via up regulation of its target gene, 15/February/2014, 12.35 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

 

 

Share
Start Typing